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AbstrACt
Objectives The aim of our work was to analyse the effect 
of maternal smoking on body size and body proportions 
of newborns when the mother had smoked only during 
the first trimester, in comparison with continued smoking 
after the first trimester. Furthermore, we have evaluated 
how growth restriction associated with maternal smoking 
contributes to changes in body proportions.
Design Register- based cohort study
setting Maternal Exposure (MATEX) cohort identified from 
the Finnish Medical Birth Register.
Participants Singleton births without congenital 
anomalies and missing data (1.38 million) from 1 January 
1991 to 31 December 2016.
Methods Logistic regression was used to quantify the 
effect of maternal smoking, stratified by the maternal 
smoking status.
Outcome measures Body proportions indicated by low 
brain- to- body ratio (defined as <10th percentile); high 
ponderal index and high head- to- length ratio (defined as 
>90th percentile); small body size for gestational age at 
birth (defined as weight, length or head circumference 
<10th percentile) and preterm birth (<37 weeks) and low 
birth weight (2500 g).
results Continued smoking after the first trimester was 
associated with high ponderal index (OR 1.26, 95% CI 1.23 
to 1.28), low brain- to- body ratio (1.11, 1.07–1.15) and 
high head- to- length ratio (1.22, 1.19–1.26), corresponding 
with absolute risks of 22%, 10% and 19%, respectively). 
The effects were slightly lower when smoking had been 
quit during the first trimester. Similar effects were seen 
for the body size variables and low birth weight. Preterm 
birth was not associated with smoking only during first 
trimester.
Conclusions Maternal smoking, independent of smoking 
duration during pregnancy, was associated with abnormal 
body proportions resulting from larger reduction of length 
and head circumference in comparison to weight. The 
effects of having quit smoking during the first trimester 
and having continued smoking after the first trimester 
were similar, suggesting the importance of early pregnancy 
as a sensitive exposure window.
IntrODuCtIOn
Smoking during pregnancy increases the risk 
for adverse pregnancy outcomes. Adverse 
pregnancy outcomes are not only associated 
with complications in the neonatal period, 
but also much later, potentially in late adult-
hood.1 Tobacco smoke contains thousands 
of chemicals, which can cross the placenta 
and enter fetal circulation. Among them, 
nicotine has a multitude of adverse effects on 
the development of organs including brain.2 
Other well- known toxic chemicals in tobacco 
smoke include carbon monoxide, which can 
interfere with oxygen supply of the unborn 
child, as well as genotoxic and carcino-
genic polycyclic aromatic hydrocarbons and 
tobacco- specific nitrosamines, which are tera-
togenic in animal studies.3
The association between maternal smoking 
and low birth weight, commonly defined 
as weight below 2500 g, is well established. 
In addition, data on the susceptibility of 
anthropometric indices, such as body length, 
head size and abdominal circumference to 
maternal smoking is emerging.4 Low birth 
weight as such does not hold information 
whether the reduction of weight is due to loss 
of lean or fat body mass. Similarly, reduction 
in any anthropometric index alone fails to 
strengths and limitations of this study
 ► The register- based design of this study provided a 
big study size to detect small risks and minimises 
risks for recall bias.
 ► The register- based design of this study allowed for 
sensitivity analyses including stratification by socio-
economic status and birth year, as well as testing of 
additional adjustment models for sociodemographic 
factors and comorbidities.
 ► The data content of the Finnish Medical Birth Register 
has been validated for accuracy and completeness.
 ► Smoking status was self- reported during antenatal 
visits, leading to possible reporting bias.
 ► The register- based design restricted availability of 
information on confounders. Thus, lifestyle- related 
confounders, such as alcohol consumption and ex-






ay 11, 2021 at T








pen: first published as 10.1136/bm





2 Rumrich I, et al. BMJ Open 2020;10:e033465. doi:10.1136/bmjopen-2019-033465
Open access 
identify abnormal body proportions. Symmetrical growth 
restriction in utero is a stronger risk factor for later 
life morbidity and mortality than asymmetrical growth 
restriction with decreased amount of fat tissue.5 Small for 
gestational age, used as a substitute for in utero growth 
restriction, is not an optimal proxy.6 This clearly demon-
strates the importance of body proportions for future 
health of the newborn.
The effects of early smoking cessation on body size are 
not well understood. Smoking only during early preg-
nancy has been shown to be less harmful on body size 
than continued smoking during late pregnancy. Previous 
small studies have indicated that anthropometric indices 
in newborns exposed only during early pregnancy are 
similar to those in newborns of non- smoking mothers.7 On 
the other hand, current bigger studies report increased 
risk for growth restriction even in fetuses exposed only 
during the first trimester.8 There are insufficient data 
about anthropometric indices, other than birth weight, 
in newborns exposed only during early pregnancy in 
comparison with newborns of non- smokers.9
The aim of our work was to analyse the effect of 
maternal smoking on body size and body proportions of 
newborns when the mother had smoked only during the 
first trimester, in comparison with newborns of mothers 
having continued smoking after the first trimester. 
Furthermore, we studied how growth restriction associ-
ated with maternal smoking contributes to abnormal 
body proportions. For this, we used the MATEX cohort 
identified from the Finnish Medical Birth Register.10 Addi-
tionally, we discuss the possibility of mechanistic interpre-
tations of differences in body proportions in newborns of 
smoking mothers compared with non- exposed newborns.
MAterIAls AnD MethODs
study design
To study the effects of maternal smoking on body size 
and proportions at birth, we conducted a register- based 
cohort study using the Finnish MATEX cohort. The 
MATEX cohort was identified from the Finnish Medical 
Birth Register. It is described in more detail elsewhere.10 
The Finnish Medical Birth register contains perinatal 
outcomes, pregnancy characteristics and sociodemo-
graphic information for all live births and stillbirths after 
the 22nd gestational week or with a birth weight of at least 
500 g. The Medical Birth Register receives information 
from standardised forms filled out by nurses and midwives 
during antenatal care visits and after the delivery of the 
baby.
This work focused on the effects of maternal smoking 
on singleton pregnancies delivered between the 1 January 
1991 and the 31 December 2016. From initial 1.75 million 
mother–child pairs, 1.38 million were included in the 
analyses after exclusion of multiple births, newborns 
with congenital anomalies and newborns with missing 
information on maternal smoking status or the covari-
ates (see online supplementary material, figure S1). 
Within the MATEX birth cohort, information on head 
circumference and maternal weight and height, as well as 
maternal comorbidities was available only for the subpop-
ulation born between 2004 and 2016. The subpopula-
tion included 659 157 mother–child pairs (see online 
supplementary material, figure S1). Thus, the analyses 
of endpoints related to head size (small head circum-
ference, brain- to- body ratio and head- to- length ratio), 
as well as sensitivity analyses, were limited to the smaller 
subpopulation.
exposure
Maternal smoking data are recorded in the Medical Birth 
Register during antenatal care visits as reported by the 
pregnant women. In the MATEX cohort, smoking status 
during pregnancy was assigned as three categories: (1) 
non- smoker; (2) quit smoking during the first trimester 
and (3) continued smoking after the first trimester. The 
trends in smoking during the study period have been 
described in detail elsewhere.11
Outcomes
Four groups of outcomes were included: (1) preterm 
birth (PTB); (2) low birth weight (LBW) (as a crude 
measure of small body size); (3) small body size for gesta-
tional age and (4) body proportions (table 1).
PTB was defined as a birth before gestational week 37, 
and term birth as birth during gestational week 37 or 
later.
LBW was categorised in accordance with the Interna-
tional Classification of Diseases 10th Revision (ICD-10) 
diagnostic criteria as weight below 2500 g. As the refer-
ence category normal weight was defined as 2500–4500 g, 
excluding high birth weight according to ICD-10 defini-
tion (>4500 g).
In this work, we use SGA as a general expression to 
describe the small size of the newborn. It was defined 
as measurement of body weight, body length or head 
circumference below a cut- off at 10th percentile, while 
the normal range defined as above the 10th percentile. 
Percentiles were defined based on sex- specific and parity- 
specific mean and SD for the corresponding gestational 
age (in weeks) at birth as reported in the Finnish standard 
reference population.12 It was included as an endpoint to 
take into account the impact of gestational age on body 
size.
Body proportionality was assessed by three anthro-
pometric indices in relation with each other: ponderal 
index, brain: body ratio and head: length ratio. Percen-
tiles of each ratio have been separately estimated for each 
gestational age (in weeks) at births in the study popula-
tion. The 10-90th percentiles were categorised as normal 
and used as reference, while the tails of the distribution 
(<10th percentile and >90th percentile) were categorised 
as abnormal.
Ponderal index was calculated using birth weight and 
body length (Equation 1). It was categorised normal 
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reference) and high (>90th percentile). Newborns below 
the 10th percentile were excluded.
 










Brain- to- body ratio was calculated based on head 
circumference and birth weight (Equation 2). It was cate-
gorised as low (<10th percentile of the study population) 
and normal (10-90th percentile, reference). Newborns 
above the 90th percentile were excluded.










The nominator of the formula is the estimation of 
the brain weight according to the National Institute of 
Neurological and Communicative Disorders and Stroke’s 
Collaborative Perinatal Project.13
Head- to- length ratio was calculated using head circum-
ference and body length (Equation 3). It was categorised 
normal (10-90th percentile of the study population, refer-
ence) and high (>90th percentile). Newborns below the 
10th percentile were excluded.
 











Maternal age and gestational age in weeks were used as 
continuous variables in the regression models. Parity was 
defined as nulliparous or multiparous. Sex was defined 
as male or female. Socioeconomic status (SES) was cate-
gorised as upper white collar (upper level employees 
with administrative, managerial, professional and related 
occupations), lower white collar (lower level employees 
with administrative and clerical occupations), blue collar 
(manual workers) and others (farmers, self- employed, 
students, pensioners), based on the Finnish national clas-
sification of occupations.14 An additional category (infor-
mation missing) was added to this classification.
statistical analyses
Multiple logistic regressions were performed to esti-
mate ORs with 95% CIs. The regressions were stratified 
by exposure status with no smoking as reference, that is, 
smoking after the first trimester was compared with no 
smoking, and separately smoking only during the first 
trimester was compared with no smoking. The regression 
models were adjusted for potential confounders (table 1; 
online supplementary material, chapter 3.2). The poten-
tial confounding factors were selected based on a combi-
nation of available data and previously published factors 
that could affect both maternal smoking and the outcome 
measures. The data were analysed using R Statistical 
software V.3.4.3. The study power was estimated as the 
smallest detectable risk ratio. The calculations were done 
using R Statistical Software epiR package with assumed 
95% CI and a study power of 90% (see online supplemen-
tary material, table S1).
register data permit
Due to the full register- based design of the study, noin-
formed consent was required from the study participants 
according to theFinnish Personal Data Act 1050/2018.
Patient and pubic involvement
No patients were involved in the design, recruitment or 
conduct of the study. The used register data are routinely 
collected in Finland.
results
Of all women with singleton births included in this study 
(n=1 376 778), 84.5% were non- smokers, 3.5% quit 
smoking during the first trimester and 12.0% continued 
smoking after the first trimester. Smoking pregnant 
women were younger and more likely to be nulliparous 
(table 2, supplementary material, table S2).
Any maternal smoking was associated with an increased 
risk for SGA and abnormal body proportions, while PTB 
was only associated with smoking continued after the first 
trimester (figure 1; online supplementary material, table 
S3).
Any maternal smoking increased the risk for LBW 
(<2500 g). Smoking continued after the first trimester 
in comparison to no smoking was associated with twice 
as high a risk for LBW (OR 2.22, 95% CI 2.14 to 2.30). 
Smoking only during the first trimester was also associ-
ated with an increased risk for LBW compared with non- 
smokers (OR 1.10, 95% CI 1.02 to 1.19) although not as 
strong as with continued smoking (figure 1A).
Any smoking during pregnancy was associated with an 
increased risk for weight or body length at birth being 
below the 10th percentile. Mothers who quit smoking 
during the first trimester were at elevated but not statisti-
cally significant risk for giving birth to a child with a small 
head circumference. Among the newborns of the mothers 
who continued smoking after the first trimester the risk 
for small head circumference was clearly increased with 
an OR of 1.64 (95% CI 1.60 to 1.68) (figure 1A).
The risk for abnormal body proportions of newborns 
was significantly increased by any maternal smoking. A 
stronger increase in risk was observed for high ponderal 
index and high head- to- length ratio than for low brain- to- 
body ratio. ORs were consistently higher if smoking was 
continued after the first trimester than when the mothers 
quit smoking during the first trimester. Nevertheless, 
smoking only during the first trimester was associated 
with statistically significantly increased risks for abnormal 
body proportions in newborns. Especially the risk for 
brain- to- body ratio was almost similar in those exposed 
only during the first trimester and those exposed also 
after the first trimester (figure 1B).
We stratified the analysis by SES to investigate the 
influence of lifestyle factors and health behaviours that 
correlate with SES. Stratification by SES did not result 
in statistically significant differences in the risk estimates 
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1 376 778 84.5% (1 163 225) 3.5% (47 819) 12% (165 734)
Mother
  Mean (SD) Mean (SD) Mean (SD) Mean (SD)
  Age (years) 29.39 (5.34) 29.78 (5.16) 27.18 (5.43) 27.3 (5.83)
  Parity (nulliparous) 59.5 (818 294) 39.4 (458 010) 58.8 (28 097) 43.2 (71 629)
  Marital status (married or partnership) 62 (846 557) 66.8 (771 065) 35.9 (17 039) 35.7 (58 453)
  Socioeconomic status % (count) % (count) % (count) % (count)
  Upper white collar worker 14.9 (205 770) 16.8 (195 402) 6.4 (3081) 4.4 (7287)
  Lower white collar worker 36.4 (501 780) 37.4 (435 623) 30.9 (14 786) 31 (51 371)
  Blue collar worker 15.1 (207 962) 13.2 (153 567) 19.2 (9189) 27.3 (45 206)
  Other 16.8 (231 481) 16.3 (189 157) 17.2 (8229) 20.6 (34 095)
  Missing 16.7 (229 785) 16.3 (189 476) 26.2 (12 534) 16.8 (27 775)
Child         
  Mean (SD) Mean (SD) Mean (SD) Mean (SD)
  Gestational age (days) 278.66 (12.05) 278.74 (11.85) 279.34 (12.11) 277.87 (13.29)
  Birth weight (g) 3549.45 (542.2) 3573.19 (536.38) 3540.62 (535.37) 3385.36 (556.1)
  Body length (cm) 50.21 (2.43) 50.32 (2.4) 50.12 (2.39) 49.5 (2.59)
  Head circumference (cm)* 34.94 (1.64) 34.99 (1.62) 34.91 (1.65) 34.55 (1.71)
  Preterm birth % (count) % (count) % (count) % (count)
  Preterm birth (<37 weeks) 4.3 (58 828) 4.1 (47 775) 4.3 (2040) 5.4 (9013)
  Low/High birth weight % (count) % (count) % (count) % (count)
  Low birth weight (<2500 g) 3.0 (40 006) 2.7 (30 443) 3.0 (1387) 5.0 (8176)
  High birth weight (>4500 g) 3.1 (41 054) 3.3 (37 165) 2.8 (1313) 1.6 (2576)
  Small for gestational age (<10th percentile) % (count) % (count) % (count) % (count)
  Weight 11.5 (158 817) 10.4 (120 800) 13.6 (6483) 19.1 (31 534)
  Body length 6.0 (81 869) 5.2 (60 003) 7.0 (3345) 11.2 (18 521)
  Head circumference (cm)* 10.9 (69 350) 10.1 (54 321) 13.3 (4675) 16.4 (10 354)
  Abnormal body proportions % (count) % (count) % (count) % (count)
  High ponderal index 11.0 (136 918) 11.1 (116 902) 11.8 (5111) 10.1 (14 905)
  Low brain- to- body ratio* 11.1 (63 520) 11.2 (54 554) 12.5 (3968) 9.2 (4998)
  High head- to- length ratio* 9.6 (60 358) 9.8 (49 830) 8.9 (3560) 8.3 (6960)
*Available since 1 January 2004.
material figure S2). We stratified the data by birth year to 
investigate potential influence of changes in the compo-
sition of tobacco (eg, use of additives and changes in 
tar and nicotine content) and decreased social accept-
ability of smoking during the study period on the risk 
estimates. Stratification by birth year did not indicate a 
clear temporal pattern in risk estimates for any of the 
analysed endpoints (see online supplementary material, 
figure S3). Sensitivity analysis was performed to test the 
sensitivity of risk estimates to choice of adjustment factors 
in the regression model. Alternative multivariate adjust-
ment models, including comorbidities or additional 
socioeconomic factors, did not significantly alter the risk 
estimates for any of the reported endpoints (see online 
supplementary material figure S4).
DIsCussIOn
In this work, we investigated the effect of maternal 
smoking during pregnancy, categorised as quit during the 
first trimester and continued after the first trimester on 
preterm birth, on body size and body proportions at birth. 
The most important finding of our study is that although 
the risk for low birth weight decreases by smoking cessa-
tion during the first trimester, brain size and body length 
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Figure 1 Adjusted ORs for association of maternal smoking with (A) traditional birth outcomes (preterm birth, low birth weight 
and small for gestational age); and with (B) abnormal body proportions; adjusted for maternal age, sex, parity, socioeconomic 
status and gestational week (for low birth weight) and weight z- score (in regressions with weight included in the dependent 
variable); marker+error bar: OR (95% CI).
the newborns exposed to maternal smoking only during 
the first trimester all three measurements of body size 
(birth weight, body length and head circumference) 
showed signs of growth restriction. In addition, body 
proportions were abnormal.
Our work indicates a difference in susceptibility for 
growth restriction between weight, body length and 
head circumference. The observed positive association 
of maternal smoking with ponderal index suggests a 
stronger reduction in length than in weight. Similarly, the 
association with low brain- to- body ratio suggests reduc-
tion rather in brain size than in weight. However, the 
association of maternal smoking with high head- to- length 
ratio suggests a stronger reduction in length than in 
head size. It is in line with previous research showing that 
smoking during pregnancy predominantly affects lean 
body mass and not fat tissue.4 While the associations with 
reduced body size and abnormal body proportion were 
stronger in newborns of mothers who continued smoking 
after the first trimester, there was a clear association also 
in newborns exposed only during the first trimester. This 
can be interpreted as an effect of maternal smoking on 
cell proliferation during organogenesis in early prenatal 
development. Insults during this period have been shown 
to persist throughout life.5 This stresses the importance of 
smoking cessation before pregnancy since even smoking 
only during early pregnancy has potentially devastating 
effects on long- term health of the unborn child.
The importance of body proportions at birth has been 
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small and thin were shown to be more likely to develop 
coronary heart disease as obese adults than their peers 
who were born small but not thin. It is not possible to 
infer from our study whether the high ponderal index 
and higher risk for shorter body length is comparable to 
stunting due to malnutrition and infections. Mechanistic 
studies of the observed effects are needed to extrapolate 
the risks to later life.
Additionally, smaller head circumference has been shown 
to directly translate into a smaller brain.16 17 Insults during 
early development of the brain, such as maternal smoking, 
have been shown to result in differences in DNA methyl-
ation, altered expression of genes regulating brain struc-
ture and function18 and reduction in neuronal content of 
the brain.19 Also, neurophysiological functions and overall 
brain functions are altered due to prenatal smoking.20 
The smaller brain volume observed in newborns has been 
shown to persist into young adulthood.21
Overall, our results are in line with previously reported 
studies by other groups (see online supplementary mate-
rial, table S4).22–25 Smoking quit during the first trimester 
had a weaker effect on reduction in weight or length 
measures, whereas smoking especially at the end of preg-
nancy reduced femur length, abdominal circumference 
and biparietal diameter.26 A clear dose response of smoking 
(number of cigarettes per day) on reduction of birth weight 
and increase in ponderal index has been demonstrated.17 27 
Previous studies examining the effect of smoking cessation 
during pregnancy have consistently reported a reduction in 
harm compared with continued smoking.4
There is increasing evidence from animal studies of nico-
tine as a causative agent for reproductive toxicity, including 
detrimental effects on brain.28 29 In a large epidemiological 
study, among the few existing ones, aberrations in lung 
development due to nicotine replacement products used 
during pregnancy has already been suggested.30 Epidemi-
ological studies on the effects of nicotine products, other 
than cigarettes, are still needed. We recommend the inclu-
sion of information on the use of nicotine products in the 
Medical Birth Register. This would allow detecting pregnan-
cies at risk more reliably and facilitating epidemiological 
research on nicotine exposure during pregnancy beyond 
maternal smoking.
This work is solely based on routinely collected register 
data, which dictates the data availability. We tested our 
results for sensitivity to different adjustment models. Our 
results were robust against inclusion of maternal comor-
bidities, maternal anthropometric indices, social back-
ground and reproductive history as confounders in the 
statistical model. Smoking and socioeconomic status have 
been shown to correlate well with other lifestyle related 
factors and they are reliable markers for the unaccounted 
factors.31 The smoking information was self- reported by 
the mother during antenatal care visits. Thus, reporting 
bias cannot be excluded. It was not possible to analyse the 
impact of timing of smoking cessation in more detail or 
possible dose–response relationships due to lack of data. In 
addition, we lack information on paternal and household 
smoking. Secondhand tobacco smoke exposure during 
pregnancy has been shown to increase the risk for low birth 
weight and growth restriction.32 We cannot exclude the 
possibility that some observed effects are partly attributable 
to secondhand tobacco smoke exposure, especially in those 
women who ceased smoking during their first trimester. 
Our definition of indicators for body proportions were 
constrained by available data in the register. Ideally, the 
outcomes in this work would be supplemented with clinical 
criteria collected during for example prenatal ultrasound 
scans, such as femur length, abdominal circumference and 
skinfold thickness. Further, the cut- off at the 10th percen-
tile for the definition of small body size and abnormal body 
proportions was arbitrary due to a lack of clear data on a 
threshold for increased risk for complications later in life. 
Socioeconomic status was assigned here solely on maternal 
occupation and no information about the father’s occupa-
tion was available. For a high proportion of mothers (18%) 
the occupation was not available. Previous studies applied 
the same SES categorisation and showed that the missing 
information did not bias the proportions in the other SES 
categories.24
Study strengths include the register- based design with a 
large study size and practically complete population repre-
sentativeness. Earlier analyses on the occupation codes 
available in the Medical Birth Register have shown that the 
socioeconomic confounding is reasonably well taken into 
account. Overall, occupation is well correlated with educa-
tion and income in Finland, and it can be used as an indi-
cator for socioeconomic health differences.33 34 An earlier 
study showed a reasonable match between serum cotinine 
and self- reported smoking status as applied in the Medical 
Birth Register.35
COnClusIOns
This study showed that maternal smoking is associated with a 
stronger reduction in body length and head circumference 
than in birth weight, leading to changed body proportions. 
The effects on body proportions of having quit smoking 
during the first trimester or having continued smoking 
after the first trimester were similar, stressing the impor-
tance of early pregnancy as a sensitive exposure window. 
Furthermore, it suggests a limited potential to repair fetal 
damage induced in early pregnancy. Lower brain- to- body 
ratio suggests that any smoking during the pregnancy may 
lead to losses in the development of central nervous system. 
The effects on body size (weight, length and head circum-
ference) were more pronounced in newborns of mothers 
who continued smoking after the first trimester.
It seems important to study the association of growth 
restriction and other adverse effects with the use of nico-
tine therapy products, as already demonstrated in animal 
studies. Until their safety has been proven, caution should 
be taken when advising pregnant women. Routine collec-
tion of information on the use of nicotine replacement 
products in the Medical Birth Register is needed for more 
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scientific research on specific effects associated with nico-
tine replacement products.
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